Skip to main content

Equibles does not estimate personal net worth.

About Susan Mahony

Zymeworks Inc. reported in an 8-K filed October 18, 2024 that Susan Mahony was appointed chair of the Board's compensation committee, effective December 10, 2024. Zymeworks Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Zymeworks Inc. includes Ali Tehrani (CEO), Kenneth Galbraith (CEO and CFO), Kristin Stafford (CFO) and 7 others.

“(ii) appointed Dr. Susan Mahony, a current member of the Board and a member of the Board's compensation committee, as chair of the Board's compensation committee to replace Mr. Renton”
Zymeworks Inc. Form 8-K, filed October 18, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Zymeworks Inc.

Recent activity